Yaxincheng

Focusing on medical translation for over 20 years
    

Company Profile

Beijing Yaxincheng Medical InfoTech Co., Ltd., a wholly-owned subsidiary of Tigermed Group, is one of the World’s leading medical device and pharmaceutical translation service providers, with a registered capital of RMB 10 million. For over 20 years, we specialise exclusively in medical translation services for the life sciences industry. We take pride in the work we do, thanks to the clear goal of providing our clients with language solutions that eventually saves lives.

Company Culture

Mission

Innovation Leadership, Global Excellence
Advance human health through excellence.

Vision

To be recognized as the globally leading medical LSP

Values

Honest & Reliable,Open & Inclusive
Professional &Innovative,Collaborative &Accountable

Mission

Innovation Leadership, Global Excellence
Advance human health through excellence.


Vision

To be recognized as the globally leading medical LSP


Values

Honest & Reliable,Open & Inclusive
Professional &Innovative,Collaborative &Accountable

Company History

2000
2003
2007
2011
2015
2016
2017
2020
Now

Development Concepts

img img

Management Team

Ruifeng Yang

Founding partner

Yaxincheng CEO

Tigermed VP

img

Shuyan Hu

Co-founder

Deputy General Manager

img

Lijun Wang

Founding partner

Deputy General Manager

img

Xiaobo Wang

VP of Tigermed Group

Deputy General Manager

img

Consultant Team

Yong Li

Organizational and Talent

Development Consultant

img

Jianqing Chang

Policy and Regulatory

Affairs Consultant

img

Jessica Liu

M&A and International

Business Consultant

img

Peter Wang

Yaxincheng Business

Development Consultant

img
img
img

Yingchun Fu

Co-founder

Co-founder of Beijing Yaxincheng Medical InfoTech Co., Ltd. MBA degree at Chinese University of Political Science and Law; EMBA degree at University of International Business and Economics; over 20 years experience in language service management. He founded Yaxincheng in 2000, which became a wholly owned subsidiary of Tigermed in 2020.